11 – 18 of 18
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- « previous
- 1
- 2
- next »
- 2015
-
Mark
Electrolyte disorders assessment in solid tumor patients treated with anti-EGFR monoclonal antibodies : a pooled analysis of 25 randomized clinical trials
(2015) In Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 36(5). p.82-3471
- Contribution to journal › Article
- 2013
-
Mark
Pharmacology of ADP-ribosylation
- Contribution to journal › Article
-
Mark
PARP inhibitors : polypharmacology versus selective inhibition
- Contribution to journal › Scientific review
-
Mark
Indenoindolone derivatives as topoisomerase II-inhibiting anticancer agents
- Contribution to journal › Article
- 2001
-
Mark
The Swedish Council on Technology Assessment in Health Care (SBU) systematic overview of chemotherapy effects in some major tumour types--summary and conclusions
- Contribution to journal › Scientific review
- 1995
-
Mark
Navoban (tropisetron) alone and in combination with dexamethasone in the prevention of chemotherapy-induced nausea and vomiting : the Nordic experience. The Nordic Antiemetic Trial Group
- Contribution to journal › Article
- 1994
-
Mark
A randomized, multicenter study comparing the efficacy and tolerability of tropisetron, a new 5-HT3 receptor antagonist, with a metoclopramide-containing antiemetic cocktail in the prevention of cisplatin-induced emesis
- Contribution to journal › Article
-
Mark
Tropisetron (Navoban) in the prevention of chemotherapy-induced nausea and vomiting--the Nordic experience
- Contribution to journal › Article
- « previous
- 1
- 2
- next »
